Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-11-18 Sale | 2022-11-22 9:45 pm | Vigil Neuroscience Inc. | VIGL | Papapetropoulos Spyros Chief Medical Officer | 300 | $14 | $4,200 | 153,604 (Direct) | View |
| 2022-05-16 Purchase | 2022-05-17 9:06 pm | Vigil Neuroscience Inc. | VIGL | Thorp Clay Director | 36,695 | $2.8454 | $104,411 | 1,559,030 (Indirect Direct) | View |
| 2022-05-05 Purchase | 2022-05-06 07:00 am | Vigil Neuroscience Inc. | VIGL | Thackaberry Evan SVP, Head of Early Development | 1,500 | $4 | $6,000 | 1,500 (Direct) | View |
| 2022-05-03 Purchase | 2022-05-04 07:00 am | Vigil Neuroscience Inc. | VIGL | Verni Christopher General Counsel | 4,000 | $3.7686 | $15,074 | 4,000 (Direct) | View |
| 2022-05-02 Purchase | 2022-05-04 07:00 am | Vigil Neuroscience Inc. | VIGL | Magovcevic-Liebisch Ivana President and CEO | 5,000 | $3.6758 | $18,379 | 203,687 (Direct) | View |
| 2022-05-03 Purchase | 2022-05-04 07:00 am | Vigil Neuroscience Inc. | VIGL | Ziolkowski Jennifer Lynn Chief Financial Officer | 4,000 | $3.7744 | $15,098 | 4,000 (Direct) | View |
| 2022-05-03 Purchase | 2022-05-04 07:00 am | Vigil Neuroscience Inc. | VIGL | Papapetropoulos Spyros Chief Medical Officer | 4,000 | $3.3978 | $13,591 | 4,000 (Direct) | View |
| 2022-03-28 Purchase | 2022-03-28 4:44 pm | Vigil Neuroscience Inc. | VIGL | Thorp Clay Director | 3,000 | $7.2014 | $21,604 | 1,522,335 (Indirect Direct) | View |
| 2022-01-11 Purchase | 2022-01-11 9:20 pm | Vigil Neuroscience Inc. | VIGL | Thorp Clay Director | 265,000 | $14 | $3,710,000 | 1,519,335 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-05-08 Option Award | 2023-05-09 4:10 pm | N/A 2033-05-07 | Vigil Neuroscience Inc. | VIGL | Budd Haeberlein Samantha L. Director | 30,694 | $0 | 30,694 (Direct) | View |
| 2023-03-01 Option Award | 2023-03-03 5:14 pm | N/A 2033-03-01 | Vigil Neuroscience Inc. | VIGL | Magovcevic-Liebisch Ivana President and CEO | 370,000 | $0 | 370,000 (Direct) | View |
| 2023-03-01 Option Award | 2023-03-03 5:13 pm | N/A 2033-03-01 | Vigil Neuroscience Inc. | VIGL | Bruhn Suzanne Louise Director | 6,235 | $7.618 | 6,235 (Direct) | View |
| 2023-03-01 Option Award | 2023-03-03 5:12 pm | N/A 2033-03-01 | Vigil Neuroscience Inc. | VIGL | Booth Bruce Director | 9,713 | $7.618 | 9,713 (Direct) | View |
| 2023-03-01 Option Award | 2023-03-03 5:11 pm | N/A 2033-03-01 | Vigil Neuroscience Inc. | VIGL | Verni Christopher General Counsel | 85,000 | $0 | 85,000 (Direct) | View |
| 2023-03-01 Option Award | 2023-03-03 5:08 pm | N/A 2033-03-01 | Vigil Neuroscience Inc. | VIGL | Thackaberry Evan SVP, Head of Early Development | 65,000 | $0 | 65,000 (Direct) | View |
| 2023-03-01 Option Award | 2023-03-03 5:08 pm | N/A 2033-03-01 | Vigil Neuroscience Inc. | VIGL | Blanchard Cheryl R Director | 6,432 | $7.618 | 6,432 (Direct) | View |
| 2023-03-01 Option Award | 2023-03-03 5:08 pm | N/A 2033-03-01 | Vigil Neuroscience Inc. | VIGL | Ziolkowski Jennifer Lynn Chief Financial Officer | 135,000 | $0 | 135,000 (Direct) | View |
| 2023-02-27 Option Award | 2023-02-27 7:04 pm | N/A 2033-02-26 | Vigil Neuroscience Inc. | VIGL | Gray David L. F. Chief Science Officer | 267,000 | $0 | 267,000 (Direct) | View |
| 2022-11-18 Exercise | 2022-11-22 9:45 pm | N/A N/A | Vigil Neuroscience Inc. | VIGL | Papapetropoulos Spyros Chief Medical Officer | 300 | $1.89 | 153,604 (Direct) | View |
| 2022-11-18 Exercise | 2022-11-22 9:45 pm | N/A 2030-11-18 | Vigil Neuroscience Inc. | VIGL | Papapetropoulos Spyros Chief Medical Officer | 300 | $0 | 153,604 (Direct) | View |
| 2022-07-27 Option Award | 2022-07-28 08:36 am | N/A 2032-07-26 | Vigil Neuroscience Inc. | VIGL | Bruhn Suzanne Louise Director | 24,310 | $0 | 24,310 (Direct) | View |
| 2022-06-09 Option Award | 2022-06-13 4:06 pm | N/A 2032-06-09 | Vigil Neuroscience Inc. | VIGL | Vitorovic Stefan Director | 12,155 | $0 | 5,028,084 (Direct) | View |
| 2022-06-09 Option Award | 2022-06-13 4:05 pm | N/A 2032-06-09 | Vigil Neuroscience Inc. | VIGL | Koenig Gerhard Director | 12,155 | $0 | 12,155 (Direct) | View |
| 2022-06-09 Option Award | 2022-06-13 4:05 pm | N/A 2032-06-09 | Vigil Neuroscience Inc. | VIGL | Blanchard Cheryl R Director | 12,155 | $0 | 12,155 (Direct) | View |
| 2022-06-09 Option Award | 2022-06-13 4:05 pm | N/A 2032-06-09 | Vigil Neuroscience Inc. | VIGL | Booth Bruce Director | 12,155 | $0 | 5,849,029 (Direct) | View |
| 2022-06-09 Option Award | 2022-06-13 4:05 pm | N/A 2032-06-09 | Vigil Neuroscience Inc. | VIGL | Thistle Mary Director | 12,155 | $0 | 12,155 (Direct) | View |
| 2022-04-19 Option Award | 2022-04-20 6:06 pm | N/A 2032-04-19 | Vigil Neuroscience Inc. | VIGL | Verni Christopher General Counsel | 150,000 | $0 | 150,000 (Direct) | View |
| 2022-04-18 Option Award | 2022-04-20 6:02 pm | N/A 2032-04-18 | Vigil Neuroscience Inc. | VIGL | Thistle Mary Director | 24,309 | $0 | 24,309 (Direct) | View |
| 2022-03-01 Option Award | 2022-03-03 4:06 pm | N/A 2032-03-01 | Vigil Neuroscience Inc. | VIGL | Koenig Gerhard Director | 4,351 | $9.63 | 4,351 (Direct) | View |
| 2022-03-01 Option Award | 2022-03-03 4:06 pm | N/A 2032-03-01 | Vigil Neuroscience Inc. | VIGL | Magovcevic-Liebisch Ivana President and CEO | 282,000 | $0 | 282,000 (Direct) | View |
| 2022-03-01 Option Award | 2022-03-03 4:05 pm | N/A 2032-03-01 | Vigil Neuroscience Inc. | VIGL | Booth Bruce Director | 7,577 | $9.63 | 7,577 (Direct) | View |
| 2022-03-01 Option Award | 2022-03-03 4:05 pm | N/A 2032-03-01 | Vigil Neuroscience Inc. | VIGL | Papapetropoulos Spyridon Chief Medical Officer | 75,500 | $0 | 75,500 (Direct) | View |
| 2022-03-01 Option Award | 2022-03-03 4:05 pm | N/A 2032-03-01 | Vigil Neuroscience Inc. | VIGL | Thackaberry Evan SVP, Head of Early Development | 45,000 | $0 | 45,000 (Direct) | View |
| 2022-03-01 Option Award | 2022-03-03 4:05 pm | N/A 2032-03-01 | Vigil Neuroscience Inc. | VIGL | Blanchard Cheryl R Director | 5,017 | $9.63 | 5,017 (Direct) | View |
| 2022-03-01 Option Award | 2022-03-03 4:05 pm | N/A 2032-03-01 | Vigil Neuroscience Inc. | VIGL | Ziolkowski Jennifer Lynn Chief Financial Officer | 110,000 | $0 | 110,000 (Direct) | View |
| 2022-01-11 Conversion | 2022-01-13 4:06 pm | N/A N/A | Vigil Neuroscience Inc. | VIGL | Cormorant Asset Management LP Chen Bihua Cormorant Global Healthcare Master Fund LP Cormorant Private Healthcare Fund IV LP Former 10% Owner | 616,786 | $0 | 616,786 (Indirect) | View |
| 2022-01-11 Conversion | 2022-01-11 9:33 pm | N/A N/A | Vigil Neuroscience Inc. | VIGL | AMGEN INC 10% Owner | 3,206,281 | $0 | 3,206,281 (Direct) | View |
| 2022-01-11 Conversion | 2022-01-11 9:20 pm | N/A N/A | Vigil Neuroscience Inc. | VIGL | Thorp Clay Director | 4,732,862 | $0 | 1,519,335 (Indirect) | View |